(Q40299079)

19 September 2017

CRISPR-Cas9 system-driven site-specific selection pressure on Herpes simplex virus genomes (English)

1 reference

19 September 2017

0 references

0 references

Zhihua Li

1

1 reference

19 September 2017

Yanwei Bi

2

1 reference

19 September 2017

Hongjian Xiao

3

1 reference

19 September 2017

Le Sun

4

1 reference

19 September 2017

Yuan Ren

5

1 reference

19 September 2017

Yadong Li

6

1 reference

19 September 2017

Chen Chen

7

1 reference

19 September 2017

Wei Cun

8

1 reference

19 September 2017

6 March 2017

1 reference

19 September 2017

1 reference

High-efficiency targeted editing of large viral genomes by RNA-guided nucleases

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Dynamic imaging of genomic loci in living human cells by an optimized CRISPR/Cas system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Multiplex genome engineering using CRISPR/Cas systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Improving CRISPR-Cas nuclease specificity using truncated guide RNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

CRISPR/Cas, the immune system of bacteria and archaea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Genome editing of CXCR4 by CRISPR/cas9 confers cells resistant to HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Development and applications of CRISPR-Cas9 for genome engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Efficient genome editing in zebrafish using a CRISPR-Cas system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

RNA-guided editing of bacterial genomes using CRISPR-Cas systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

STRUCTURAL BIOLOGY. A Cas9-guide RNA complex preorganized for target DNA recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

A guide to genome engineering with programmable nucleases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Replication of herpes simplex virus DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Molecular engineering of the herpes simplex virus genome: Insertion of a second L-S junction into the genome causes additional genome inversions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Targeted mutagenesis in the model plant Nicotiana benthamiana using Cas9 RNA-guided endonuclease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Double-strand break repair: 53BP1 comes into focus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Herpes simplex virus type-1: replication, latency, reactivation and its antiviral targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Resistance of herpes simplex viruses to nucleoside analogues: mechanisms, prevalence, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

An inquiry into the molecular basis of HSV latency and reactivation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

CRISPR-Cas systems for editing, regulating and targeting genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Targeting Hepatitis B Virus With CRISPR/Cas9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

DNA interrogation by the CRISPR RNA-guided endonuclease Cas9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Conformational control of DNA target cleavage by CRISPR-Cas9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

Herpes simplex virus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2017.03.010

10.1016/J.VIRUSRES.2017.03.010

7 January 2021

Identifiers

DOI

1 reference

19 September 2017

1 reference